Genfit SA GNFT-FR:Euronext Paris

*Data is delayed | EUR
Last | 07/01/22 CEST
3.08quote price arrow up+0.02 (+0.65%)
Volume
30,800
52 week range
2.75 - 4.95
Loading...
  • Open3.09
  • Day High3.09
  • Day Low3.03
  • Prev Close3.06
  • 52 Week High4.95
  • 52 Week High Date12/17/21
  • 52 Week Low2.75
  • 52 Week Low Date12/07/21

Key Stats

  • Market Cap170.42M
  • Shares Out49.82M
  • 10 Day Average Volume44,736.25
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change-28.64

KEY STATS

  • Open3.09
  • Day High3.09
  • Day Low3.03
  • Prev Close3.06
  • 52 Week High4.95
  • 52 Week High Date12/17/21
  • 52 Week Low2.75
  • 52 Week Low Date12/07/21
  • Market Cap170.42M
  • Shares Out49.82M
  • 10 Day Average Volume44,736.25
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change-28.64

RATIOS/PROFITABILITY

  • EPS (TTM)1.48
  • P/E (TTM)2.08
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genfit SA

There is no recent news for this security.

Profile

MORE
Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The Company is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver, such as Nonalcoholic steatohepatitis (NASH) or the bowel, such as the inflammatory bowel disease. The Company targets a number of...
Jean-Francois Mouney
Chairman of the Board
Xavier Guille Des Buttes
Independent Vice Chairman of the Board
Pascal Prigent
Chief Executive Officer
Dean Hum Ph.D.
Chief Operating Officer
Thomas Baetz
Chief Financial Officer
Emilie Desodt
Vice President - Human Resources
Address
Parc Eurasante 885 avenue Eugene Avinee
Loos
59120
France